May 15, 2026

SOME: sintilimab plus chemotherapy followed by definitive local therapy for oligometastatic thoracic esophageal squamous cell carcinoma—a multicenter, prospective, open-label phase II trial

Key points are not available for this paper at this time.

: Chinese Clinical Trial Registry (http://www.chictr.org.cn), identifier is ChiCTR2500108825.

AI से पूछें

Bookmark

Cite This Study

Zhang et al. (Fri,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI से पूछें

Bookmark